High levels of Bcl-2 can explain the inability of downregulation of XIAP expression to sensitise RCC cells to chemotherapeutic drugs, which are believed to trigger an intrinsic, mitochondria-mediated apoptotic pathway. The gene discussed is BCL2; the disease is renal cell carcinoma.